Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Equities

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E. 18:00:00 2024-06-17 EDT 5-day change 1st Jan Change
35.17 CNY -0.23% Intraday chart for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -4.43% +4.52%

Business Summary

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Number of employees: 4,619

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Patent Medicine
71.0 %
5,652 68.5 % 5,836 71.0 % +3.26%
Western Medicine
20.6 %
1,783 21.6 % 1,697 20.6 % -4.84%
Other
8.2 %
796 9.7 % 673 8.2 % -15.47%
Other Business
0.2 %
18 0.2 % 16 0.2 % -9.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.5 %
8,198 99.6 % 8,161 99.5 % -0.44%
Overseas
0.5 %
34 0.4 % 45 0.5 % +33.00%

Managers

Managers TitleAgeSince
Chief Executive Officer 53 22-08-21
Director of Finance/CFO 46 23-07-20
Chief Tech/Sci/R&D Officer 54 12-11-30
Director/Board Member 55 23-02-28
42 -
54 -
Investor Relations Contact - -
51 -
- -
61 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 11-27
Director/Board Member 68 20-06-04
Chief Tech/Sci/R&D Officer 54 12-11-30
Director/Board Member 53 21-12-09
Director/Board Member 54 17-07-31
Chief Executive Officer 53 22-08-21
Director/Board Member 57 21-05-16
Chairman 49 21-12-27
Director/Board Member 50 22-12-29
Director/Board Member 55 23-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 200,000,000 0 0 31.14 %
Stock B 1 570,158,276 239,803,030 ( 42.06 %) 1,285,200 ( 0.2254 %)

Shareholders

NameEquities%Valuation
Jinhushen Biomedical Technology Co., Ltd.
58.52 %
331,120,528 58.52 % 1 608 M ¥
Zhong Ou Asset Management Co., Ltd
1.458 %
8,249,081 1.458 % 40 M ¥
First Seafront Fund Management Co., Ltd.
1.290 %
7,299,839 1.290 % 35 M ¥
Fullgoal Fund Management Co., Ltd.
0.8057 %
4,559,276 0.8057 % 22 M ¥
3,700,000 0.6539 % 18 M ¥
GF Fund Management Co., Ltd.
0.4704 %
2,661,973 0.4704 % 13 M ¥
CITIC-Prudential Fund Management Co., Ltd.
0.3986 %
2,255,672 0.3986 % 11 M ¥
China Southern Asset Management Co., Ltd.
0.3720 %
2,105,259 0.3720 % 10 M ¥
China Asset Management Co., Ltd.
0.3162 %
1,789,344 0.3162 % 9 M ¥
Cinda Fund Management Co. Ltd.
0.2739 %
1,549,656 0.2739 % 8 M ¥
NameEquities%Valuation
Jinhushen Biomedical Technology Co., Ltd.
2.633 %
5,265,000 2.633 % 13 M ¥
RAM Active Investments SA
0.0923 %
184,500 0.0923 % 448 335 ¥

Company contact information

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

No. 17 Baidi Road Nankai District

300193, Tianjin

+

http://en.pharm.com.cn
address Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(600329)
  1. Stock Market
  2. Equities
  3. 600329 Stock
  4. Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited